SB182 • 2025

AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor: Poore
Last action: 2025-07-21
Official status: Signed 7/21/25
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.

What This Bill Does

AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.
This Act allows drug manufacturers or their agents and wholesalers to ship dialysate drugs and devices directly to home dialysis patients without a pharmacy license.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-07-21 Delaware General Assembly
Signed by Governor
2025-06-26 Delaware General Assembly
Passed By House. Votes: 40 YES 1 VACANT
2025-06-17 Delaware General Assembly
Reported Out of Committee (Sunset Committee (Policy Analysis & Government Accountability)) in House with 5 On Its Merits
2025-06-12 Delaware General Assembly
Passed By Senate. Votes: 18 YES 1 NOT VOTING 2 ABSENT
2025-06-12 Delaware General Assembly
Assigned to Sunset Committee (Policy Analysis & Government Accountability) Committee in House
2025-06-11 Delaware General Assembly
Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable
2025-06-10 Delaware General Assembly
Introduced and Assigned to Health & Social Services Committee in Senate

Official Summary Text

AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.
This Act allows drug manufacturers or their agents and wholesalers to ship dialysate drugs and devices directly to home dialysis patients without a pharmacy license.

Current Bill Text

Read the full stored bill text

Legislation Document

SPONSOR:

Sen. Poore & Sen. Pinkney & Rep. Ortega

Sens. Buckson, Hoffner, Lawson; Reps. Bolden, Morrison

DELAWARE STATE SENATE

153rd GENERAL ASSEMBLY

SENATE BILL NO. 182

AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Amend § 2523, Title 24 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 2523. Exemptions.

Nothing in this chapter may be construed to prevent any of the following:

(10) A manufacturer or wholesaler from providing distribution of dialysate drugs or devices necessary to perform home dialysis on patients with end-stage renal disease, provided that all of the following criteria are met:

a. The dialysate drugs or devices are approved by the U. S. Food and Drug Administration as required by federal law.

b. The dialysate drugs or devices are lawfully held by a manufacturer or a manufacturer’s agent that is properly registered with the Board as a manufacturer or wholesaler.

c. The dialysate drugs or devices are held and delivered in their original, sealed label packaging from the manufacturing facility.

d. The dialysate drugs or devices are delivered only by the manufacturer or the manufacturer’s agent and only upon receipt of a prescription from a practitioner.

e. The manufacturer or the manufacturer’s agent delivers the dialysate drugs or devices directly to one of the following:

1. A patient with end stage renal disease or the patient’s designee for the patient’s self-administration of dialysis therapy.

2. A health care provider or institution for administration or delivery of the dialysis therapy to a patient with end stage renal disease.

SYNOPSIS

This Act allows drug manufacturers or their agents and wholesalers to ship dialysate drugs and devices directly to home dialysis patients without a pharmacy license.

Author: Senator Poore